Allergan, Inc. today announced a new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases that found the cost of a gastric banding weight-loss surgery procedure, such as Allergan’s LAP-BAND Adjustable Gastric Banding Sy…
Category: News
Discovery Of The Cause Of Hereditary Blindness
RUB Medicine: new protein identified Initially the occurrence of progressive retinal degeneration – progressive retinal atrophy, in man called retinitis pigmentosa – had been identified in Schapendoes dogs. Retinitis pigmentosa is the most common her…
Neurobiologists Have Determined The Number Of Circuits Needed To See Movements
Surely, everybody knows this phenomenon: an animal doesn’t stand out against its background and becomes visible to us only when it moves. The reason behind this is that we depend strongly on our eyesight for navigation, and the perception of motion is …
Sight Requires Exact Pattern Of Neural Activity To Be Wired In The Womb
The precise wiring of our visual system depends upon the pattern of spontaneous activity within the brain that occurs well before birth, a new study by Yale researchers shows. “It isn’t just the genes…
Study Demonstrates Potential Of New Gene Vector To Broaden Treatment Of Eye Diseases
Inspired by earlier successes using gene therapy to correct an inherited type of blindness, investigators from the Perelman School of Medicine at the University of Pennsylvania, are poised to extend their approach to other types of blinding disorders…
Video: Carl Zeiss’ ATLAS® 9000 Corneal Topographer
Featured Article
Peak IOP A Better Predictor Of Visual Field Progression Than Mean Pressure Or Fluctuation
IOP-dependent and IOP-independent risk factors affect visual field progression in patients treated for glaucoma, with peak IOP showing a stronger correlation than mean IOP or pressure fluctuation, a study found.
Video Interview: Recent Discoveries in DSEK Surgery
Featured Article
Cause Of Hereditary Blindness Discovered
Cause of hereditary blindness discoveredInitially the occurrence of progressive retinal degeneration – progressive retinal atrophy, in man called retinitis pigmentosa – had been identified in Schapendoes dogs. Retinitis pigmentosa is the most common he…
Next Generation Gene Therapy
PHILADELPHIA – Inspired by earlier successes using gene therapy to correct an inherited type of blindness, investigators from the Perelman School of Medicine at the University of Pennsylvania, are poised to extend their approach to other types of blind…
Consumer Medication Information: One Page Fits All
Sandra Fryhofer, MD, talks about the new initiative for putting consumer drug information into a single document. Medscape Internal Medicine
EyeMed Vision Care Adds Retinal Imaging Benefit In Support Of Eye Health And Vision Wellness
EyeMed Vision Care, one of the nation’s leading vision benefits companies and part of Luxottica (NYSE: LUX), a leader in vision care and eyewear, has begun offering retinal imaging as an optional benefit within a vision plan. Retinal imaging provides d…
Human Retina Protein Has The Molecular Capability To Function As A Light-Sensitive Magnetic Sensor
For migratory birds and sea turtles, the ability to sense the Earth’s magnetic field is crucial to navigating the long-distance voyages these animals undertake during migration. Humans, however, are widely assumed not to have an innate magnetic sense…
Poor Vision Leads To Falls For 270,000 Over-60s, UK
270,000 people in the UK aged 60+ who have fallen over in the last two years say that poor vision was a factor in their fall[i], according to new research released today to mark Age UK’s Falls Awareness Week 2011 (20-24 June). Many things can lead to …
Oxford BioMedica Announces Ocular Programme Update
Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), a leading gene therapy company, today announces that the first dose level of RetinoStat(R) is safe and well-tolerated at one month following treatment…
Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
‘A Sticky Situation’ – Part II
Featured Article
Long-Term Trends Confirm Safety Of Cataract Surgery
“Although there was considerable change in operative technique, this alone may not be the sole reason for the reduction in complications; other factors not measured in this study are likely involved,” the study authors said.
Recommendations on Cell Phone Use and Cancer Risk
Evidence is limited, but common-sense precautions can be taken until the science catches up with technology. Medscape Medical News
Yissum Presents A Virtual Cane For The Visually Impaired
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, presented today at the Israeli Presidential Conference, a virtual cane that will significantly improve the orientation and mobility of sigh…